Table 2.
Predictors of BMD loss ≥ 5% at the lumbar spine or femoral neck in DMPA users over 24 months of use
| Characteristics | Odds ratio (95% CI) |
|---|---|
| Race/ethnicity | |
| Black | Reference |
| White | 0.34 (0.10–1.17) |
| Hispanic | 0.90 (0.26–3.10) |
| Previous DMPA injection (#) | 0.90 (0.80–1.02) |
| Parity | 0.49 (0.29–0.82) |
| Total calcium intake | 0.81 (0.65–0.99) |
| Current smoker | 3.88 (1.26–11.96) |
Based on logistic regression analysis
R-squared value: 0.20
Area under the ROC curve: 0.79
P value for Hosmer-Lemeshow goodness of fit test=0.25
Dependent variable: BMD loss (≥ 5% vs. <5%)
Predictors: race/ethnicity (non-Hispanic black, non-Hispanic white, Hispanic), previous use of DMPA injection (# of injection), parity (continuous), total calcium intake (in 100 mg/day), current smoker (current smoker vs. not current smoker)